glp 1 ra heart failure Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit SGLTi and GLP-1 in HF

Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus

4.1.4 Mortality and adverse events The available evidence demonstrates that GLP-1 RAs therapy reduces all-cause mortality in T2DM, including patients with chronic kidney disease and increased cardiovascular risk (53)

Available from URL: (accessed January 2026) Cuijpers P, Weitz E, Cristea IA, Twisk J

What also helped was the invention of a new sequencing technique by Frederick Sanger, a British biochemist at the University of Cambridge, which he used to crack the amino acid structure of insulin in 1955 (Marks 2015)